growth and health outcomes in donor human milk fed vlbw ... · safety of donor human milk compared...
TRANSCRIPT
Growth and Health Outcomes in Donor Human Milk Fed VLBW
Infants:Results from the DoMINO RCT
Deborah L O’Connor and Sharon Unger on behalf of the GTA DoMINO Feeding Group
Disclosure
• Drs. O’Connor and Unger serve in leadership roles at the Rogers Hixon Ontario Human Donor Milk Bank
• They lead a research program
with the aim to optimize use of human milk for Preterm Infants
Objectives 1. Review the most current systematic
review examining the efficacy and safety of donor human milk compared to preterm formula as a supplement.
2. Present growth, morbidity and neurodevelopment results from the DoMINO RCT conducted in the Greater Toronto and Hamilton area in Canada.
3. Future directions for human milk research.
Own Mother’s Milk
Own Mother’s Milk is the most appropriate source of nutrition for all infants including preterm infants:
• Well tolerated
• Associated with a reduction in late onset sepsis and NEC
• Associated with a reduction in non-specific gastroenteritis, severe lower respiratory tract infections, atopic dermatitis, asthma (young children), obesity, type 1 and 2 diabetes, childhood leukemia and sudden infant death syndrome.
• Duration and exclusivity of own mother’s milk feeding associated with superior neurocognitive development
Kim JH and Unger S. CPS Position Statement on Milk Banking. Paediatr Child Health 2010;15(9):595-8; U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Support Breastfeeding. Washington, DC, 2011
Effect of Breast Milk Feeding on Neurodevelopment*
Outcome Parameter Estimate (For each 10 ml/kg/d
HM intake)
P-value
Cognitive Score (MDI) 0.53 0.0002
Motor Score (PDI)
0.63 <0.0001
Behavioural Rating Scale (BRS)
0.82 0.0025
Vohr et al Pediatrics 2006;118(1):e115-23; Vohr et al Pediatrics 2007;120(4):e 953-9
*Statistically controlled for demographic and clinical confounders
So why not just feed mother’s own milk?
Most Mothers of Very Preterm Infants are Unable to Provide a
Sufficient Volume of Milk
• Immaturity of the mammary secretory cell • Mother may be ill • Stress • Mother and Infant may be separated • Mothers are pump-dependent
Processing Donor Milk
Freezing, storage, and transport
Thawing and Bacterial culture
Batching
Pasteurization
Culture of batch
Milk analysis
Freezing
Courier to institution
Pasteurization Process Impacts the Nutritional Composition of Human Milk
• Stage during lactation when milk is collected • Freezing and thawing • Heat Treatment • Container Changes • Feeding Tubes
Bioactive Components in Human Milk
Ewaschuk JB et al Appl Physiol Nutr Metab 36:175-182, 2011
Adiponectin Gonadotropin Mucins α-Lactoglobulin Glutathione peroxidase Ν-Acetyl-glucosamine Antisecretory lectins Granulocyte-colony stimulating factor Nucleotide-hydrolyzing antibodies α-Tocopherol GRP Neurotensin Ascorbate Haptocorrin Neutrophils β-Carotene Hepatocyte growth factor NGF B-cells Human-chorionic gonadotropin Nucleotides β-Defensin-1 Hypothalamus-related hormones Oligosaccharides Bifidogenic peptides (hLACFR-la) IFN-γ Osteoprotegerin Bididus factor IGF-1 Peptide YY Bombesin IGF-11 Platelet activating factor acetylhydrolase Catalase IL-1 receptor agonist Prebiotics Complement (C3, C4) IL-1b Prolactin Complement receptors (CF2, CD21) IL-2, -4, -5, -6, -8, -10, -12, -13, -16, -18 Protease inhibitors Cortisol Insulin RANTES Cysteine κ-Casein sCD14 EGF, HB-EGF Lactadherin Somatostatin Erythropoeitin Lactoferrin Substance P Estrogen, progesterone Lactoperoxidase T-cells Fibroblast growth factor LCFA-DHA, AA TGF-α Free secretory protein Leptin TGF-β Gangliosides Leukocytes Thyroid hormones Gastrin Lysozyme TLRs Ghrelin Macrophages TNF-α GIP MCFA Vasoactive intestinal peptide MCP-1
Effect of Holder Pasteurization on Breastmilk Components
O’Connor DL Curr Opin Clin Nutr Metab Care 18:269-275, 2015.
Important Points About the Systematic Review
• Study Selection criteria Randomized or quasi-randomized studies included 9 trials included: Raiha 1976; Davies 1977; Schultz 1980; Gross
1983; Tyson 1983; Lucas 1984a; Lucas 1984b; Schanler 2005; Cristofalo 2013
• Characteristics of randomized subjects 1070 infants; Most <1800 g and 32 weeks gestational age
(clinically stable) Most trials excluded SGA infants
• Enteral feeds 4 trials compared term formula vs donor milk 5 trials compared preterm formula vs donor milk Only the two most recent trials used nutrient fortification
Formula versus Donor Milk for Feeding Preterm or Low Birth Weight Infants: NEC
Cochrane Database of Systematic Reviews 22 APR 2014 DOI: 10.1002/14651858.CD002971.pub3 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002971.pub3/full#CD002971-fig-0006
Cochrane Database of Systematic Reviews 22 APR 2014 DOI: 10.1002/14651858.CD002971.pub3 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002971.pub3/full#CD002971-fig-00122
Formula versus Donor Milk for Feeding Preterm or Low Birth Weight Infants:
Feeding Intolerance
Cochrane Database of Systematic Reviews 22 APR 2014 DOI: 10.1002/14651858.CD002971.pub3 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002971.pub3/full#CD002971-fig-0003
Formula versus Donor Milk for Feeding Preterm or Low Birth Weight Infants:
Weight Gain
Cochrane Database of Systematic Reviews 22 APR 2014 DOI: 10.1002/14651858.CD002971.pub3 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002971.pub3/full#CD002971-fig-0004
Formula versus Donor Milk for Feeding Preterm or Low Birth Weight Infants:
Length Gain
Cochrane Database of Systematic Reviews 22 APR 2014 DOI: 10.1002/14651858.CD002971.pub3 http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002971.pub3/full#CD002971-fig-0005
Formula versus Donor Milk for Feeding Preterm or Low Birth Weight Infants:
Head Circumference Gain
Potential Risk of Donor Milk as a Supplement: Cochrane Review
Mean rate of weight gain was <15 g/kg/d in 6 of 8 trials for infants fed donor milk
Distribution of Cases of NEC according to GA and Postmenstrual age (PMA) in the Study Cohort
Yee W H et al. Pediatrics 2012;129:e298-e304
©2012 by American Academy of Pediatrics
Authors’ Conclusions • Many of the trials very old; more mixed feeding in current
NICUs; only two trials used nutrient-enriched human milk
Applicability to current practice
If you start adding nutrients to donor milk to correct growth will you negatively impact NEC-protection?
• High risk preterm infants excluded from many studies—i.e. SGA infants
• Future studies should ensure caregivers and assessors are blind to intervention
• Data on long-term outcomes lacking
Donor Milk for Improved Neurodevelopmental Outcomes
DoMINO ISRCTN35317141; Registered 08/2010
Unger S, Gibbins S, Zupancic J, O’Connor DL: DoMINO: BMC Pediatrics 14:123, 2014
What Will Be Our Primary Outcome Measure?
• Sample size required to examine NEC made RCT not feasible
• Neurodevelopment might be more appropriate Associated with dose of own mother’s milk-fed
(Vohr et al Pediatrics 2006;118[1]:e115-23; Vohr et al Pediatrics 2007;120[4]:e 953-9)
Associated with early growth and nutrition (Ehrenkranz RA et al 2006; Pediatrics 117[4]:1253-1260)
Hypotheses In VLBW infants, when mothers’ own milk is unavailable, provision of pasteurized donor human milk compared to preterm formula during initial hospitalization will: • improve neurocognitive development at 18-24
months CA • reduce neonatal mortality and morbidity • support growth • Produce a gut microbial community composition
more like the exclusively mother’s own milk fed infant
• show an acceptable cost effectiveness from a societal perspective?
Study Design
• Multi-centered double-blinded RCT 4 recruiting centres (Level III)
Total of 18 hospitals participating
• Infants randomized within 96 hr of birth using a 3rd party service
• Infants continue to receive study feedings after transfer to a participating Level II
Inclusion/Exclusion
Inclusion • <1500 g
Exclusion • Severe congenital or chromosomal anomlies that
may contribute to poor neurodevelopment • Reasonable potential infant would be transferred
to a NICU where we did not have ethics approval
Milk Preparation Room
Details of Donor Milk
• Mother’s Milk Bank of Ohio Milk expressed in the 1st 3 months
postpartum
• Back-up: Calgary Mother’s Milk Bank • Once donor milk was fortified, a protein
modular was added (0.4 g/dl)
Feeding Guidelines
Rouge Valley Health System
Frequency and Duration of Follow-up
Subject Disposition
Current participants (n=316)
Deaths (n=37)
*Target: 363 randomized infants
Infants Approached to Participate (n=840)
Declined (n=477)
Infants Randomized (n=363)
Withdrawn from feeding intervention but consent to follow
outcome (n=34)
Withdrawals from the study (n=10)
Baseline Characteristics Donor Milk
(n=181) Preterm Formula
(n=182) P-value Sex, n (%) NS
Female 80 (44.2) 88 (48.4) Male 101 (55.8) 94 (51.6)
Birth weight, g, mean + SD 995+273 996+272 NS Birth Size, n (%) NS
Singleton 121 (66.9) 113 (62.1) Multiple 60 (33.1) 69 (37.9)
Small for gestational age, n (%) 21 (11.6) 24 (13.2) NS Apgar score at 5 min, mean + SD 6.9+2.3 7.0+2.4 NS Maternal Age, yr, 31.4+5.9 32.6+6.4 NS Mother's Education, n (%)
High School or less 49 (29.0) 39 (22.3) NS College/vocational diploma 47 (27.8) 55 (31.4) Baccalaureate 46 (27.2) 46 (26.3) Post Baccalaureate 27 (16.0) 27 (20.0)
Exposure to Own Mother’s Milk and Duration of Feeding
Intervention
Donor Milk (n=181)
Preterm Formula (n=182) P-value
Unpublished data to be presented
*Median (1st and 3rd quartiles)
Mortality and Major Morbidities Donor Milk Preterm Formula P-value
(n=181 ) (n=182 )
Unpublished data to be presented
Blinded NEC Evaluation
Team: neonatology and radiology Evaluation: clinical course, x-rays,
ultrasounds, surgical course, pathology Criteria: Stage 1: systemic and gastrointestinal symptoms with
non-specific x-ray changes Stage 2: systemic and gastrointestinal symptoms with
specific x-ray changes Stage 3: deterioration of vital signs/ septic shock +/-
pneumoperitoneum
Weight-for-age Z-score: Study Day 1 to End of Feeding
Intervention
Unpublished data to be presented
Length-for-age Z-score: Study Day 1 to End of Feeding
Intervention
Unpublished data to be presented
Head Circumference-for-age Z-score: Study Day 1 to End of
Feeding Intervention
Unpublished data to be presented
Cognitive, Language at Motor Development at 18-24 Months CA
Unpublished data to be presented
Is There An Advantage of an Exclusive Human Milk Diet for NEC Prevention?
Infants fed mothers’ own milk randomized to:
1. HM100 2. HM40 3. BOV
*Sullivan et al Journal of Pediatrics 2010;156:562-7.
mother’s own milk +/- donor milk human milk based fortifier
mother’s own milk +/- preterm formula bovine milk based fortifier
Is There An Advantage of an Exclusive Human Milk Diet for NEC Prevention?
*Sullivan et al Journal of Pediatrics 2010;156:562-7.
Unanswered question: Was it the donor milk or the human milk based fortifier that resulted in the significant reductions in NEC?
OptiMoM Program
• Comparison of human milk-based and bovine milk-based fortification; (feeding tolerance, growth, GIT microbiome, gut inflammation)
• Long-term follow-up of DoMINO babies at Kindergarten; (neurodevelopment, neuroimaging, body composition, genotyping)
• Comparison of higher versus lower protein intake (5.0 vs 3.5 g/kg/d); (neurodevelopment, neuroimaging, growth, body composition, morbidity)
Conclusions
• Cochrane Review: Use of donor milk compared to formula as a supplement is associated with a lower risk of NEC in VLBW infants but growth outcomes are inconsistent with optimal neurodevelopment.
• DoMINO Trial: To be presented
• Future directions: Research in this area is very thin. Work is required in optimizing mother’s own milk, donor milk and fortifiers.
Current Recommendations for Human Donor Milk in Ontario, Canada
Eligibility: • <1500 g at birth • <32 weeks 6 days at birth • GI or cardiac surgery
Duration: • 4 weeks • Until 32 weeks and 6 days
http://www.milkbankontario.ca/